Project Details
Description
A Phase III study of JR-141 in Mucopolysaccharidosis type II (Hunter Syndrome) patients
| Status | Active |
|---|---|
| Effective start/end date | 11/15/22 → 11/16/25 |
Funding
- JCR PHARMACEUTICALS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.